Sea
Senior Member
- Messages
- 1,286
- Location
- NSW Australia
Given that the Griffiths University team seem to be the most active in ME research, given they have a clinic and given that they have done some work on B cells, they seem to be the most likely to be interested in running a trial. They were also represented at the recent London conference I think and so will know all about the Rituximab trials.
I'm flagging some of you who I know are based in Australia. I know some of you are close to the Griffiths team. Is there any indication that they are thinking about a trial? Any ideas on how we might encourage them if the Phase 3 trial looks good? What would be the factors slowing down the establishment of such a trial - other than funding?
I haven't heard them mention Rituximab at all. The researchers are mostly PhD students, under supervision, looking for a breakthrough in finding a biomarker. I don't know if there will be any interest in treating based on others findings. I would imagine if Rituximab were made available to us it would be delivered by those who are already familiar with its use in other illnesses.
I haven't worked out yet what the point of their clinic is. They are not offering treatment of any kind. The Dr said they cannot discuss the research at the clinic appointment because they are funded separately (Clinic appointments are reimbursed by Medicare, research is Government grant funded)